UBS Group
MDGSW

UBS Group’s Medigus Ltd. Series C Warrant MDGSW Stock Holding History

UBS Group’s Portfolio MDGSW Stock Details MDGSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,855
Closed -$97 – 10336
2023
Q2 		$97 Sell
2,855
-2,241
-44% -$139 ﹤0.01% 8517
2023
Q1 		$148 Sell
5,096
-90,364
-95% -$6.49K ﹤0.01% 9177
2022
Q4 		$5.73K Sell
95,460
-2,002
-2% -$339 ﹤0.01% 9138
2022
Q3 		$10K Buy
97,462
+97,440
+442,909% +$16.1K ﹤0.01% 8509
2022
Q2 		$0 Hold
22
– – ﹤0.01% 11353
2022
Q1 		$0 Buy
+22
New +$7 ﹤0.01% 11252
2021
Q4 		– Sell
-4,900
Closed -$2K – 10992
2021
Q3 		$2K Buy
4,900
+4,096
+509% +$2.01K ﹤0.01% 9040
2021
Q2 		$0 Sell
804
-22
-3% -$15 ﹤0.01% 10028
2021
Q1 		$1K Buy
826
+589
+249% +$504 ﹤0.01% 8832
2020
Q4 		$0 Sell
237
-2,864
-92% -$965 ﹤0.01% 8924
2020
Q3 		$1K Buy
3,101
+1,600
+107% +$330 ﹤0.01% 7874
2020
Q2 		$0 Buy
+1,501
New +$515 ﹤0.01% 8498

UBS Group's MDGSW Position: Q3 2023 in Review

UBS Group sold out of Medigus Ltd. Series C Warrant (MDGSW) in Q3 2023, closing a stake of 2,855 shares — an estimated $97 sold.

UBS Group first reported a position in MDGSW in Q2 2020 and held it in 12 quarters. The position peaked at $10K in Q3 2022. 0 funds tracked by Wall St. Rank hold MDGSW as of Q3 2023.

  • UBS Group reported no remaining Medigus Ltd. Series C Warrant position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 2,855 Medigus Ltd. Series C Warrant shares in Q3 2023, an estimated $97.
  • UBS Group first reported a position in Medigus Ltd. Series C Warrant in Q2 2020 and held it in 12 quarters.
  • UBS Group's Medigus Ltd. Series C Warrant position peaked at $10K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Medigus Ltd. Series C Warrant as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.